Frontlight ResearchEarly access
Trial site
US Oncology Investigational Products Center
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Diffuse large B-cell lymphoma2 trials
- Lung cancer2 trials
- Colorectal cancer1 trial
- Follicular lymphoma1 trial
- Kidney cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 36 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed1 trial
- Terminated1 trial
- Lead sponsor
- Pfizer7 trials
- Seagen, a wholly owned subsidiary of Pfizer1 trial
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026